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The present study tests the hypothesis that the difference in the
intensity of paw edema found between the Dark Agouti (DA) and Albino
Oxford (AO) rat strains originates from the distinct participation of
histamine, serotonin and their corresponding receptors in
Concanavalin A (Con A)-induced inflammation. DA and AO male rats
were intraplantarly injected with specific receptor antagonists prior to
Con A, and the intensity of inflammation was determined by measuring
the paw diameter.
Our results have showed that histamine H1 and H2 receptor
antagonists reduced the Con A-induced paw edema in DA rats, while
serotonin 5HT3 receptor antagonist diminished the inflammation in both
DA and AO rat strains. The calcium channel blocker did not change
Con A-induced inflammation.
Strain differences in the intensity and kinetics of inflammation
observed between the DA and AO rats are most likely defined by the
diversity of mediators released and their receptors activated upon Con
A injection.
Key words: Albino Oxford (AO) rat, antagonists, Concanavalin A
(Con A), Dark Agouti (DA) rat, paw edema
INTRODUCTION
T cell mitogen concanavalin A (Con A), a glycan-binding protein isolated
from the seeds of jack beans (Canavalia ensiformis), is widely used for in vitro
studies of the mechanisms involved in T cells activation (Di Sabato et al., 1987).
Con A in vivo stimulates T cell proliferation and activates macrophages (Deng et
al., 1996), either via direct binding to macrophage surface (Barral-Netto and
Barral, 1986) or by the activation of lymphocytes. Furthermore, Con A recruits
cells to the peritoneal cavity (Rodriguez et al., 1992) and stimulates macrophage
nitric oxide (NO) production (Andrade et al., 1999). Intravenous or retro-orbital
application of Con A at substantially high doses (10-30 mg/kg) causes severe
hepatitis in mice, characterized by the inflammatory infiltration (neutrophils,
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macrophages, and T cells) into the liver and the release of various cytokines,
including tumor necrosis factor alpha (TNF) (Tiegs et al., 1992). In contrast, a
non-hepatotoxic dose of Con A (3 mg/kg) induces high levels of interleukin (IL)-6
and prevents liver damage provoked by the high dose of Con A (Xu et al., 2006).
Accordingly, Con A seems to be an activator of the immune system at multiple
levels.
It has been reported that Con A injected in the footpads of mice and rats
induces an intense and reproducible inflammatory response characterized by
edema, erythema and induration at the site of the injection (Shier et al., 1974;
Vuji}-Red`i} et al., 2000). The Con A-induced local inflammatory response is a
valuable tool for rapid testing of potential anti-inflammatory drugs. However, we
have observed significant strain differences in the intensity of Con A-induced paw
edema in rats. Depending on the rat strain, the increase of paw diameter varies
from 28% to 82% and reaches its maximum at different time points following the
injection of Con A. Intraplantar, intraperitoneal or intracerebroventricular
application of the opioid peptides methionine-enkephalin and -endorphin, as
well as anti- methionine-enkephalin antibodies and peptides belonging to the
neuropeptide Y family, also modulated the Con A-induced paw inflammation in
rats, in a receptor- and strain- specific manner (Vuji}-Red`i} et al., 2000;
Stanojevi} et al., 2006a; Stanojevi} et al., 2006b). Although several mechanisms
underlying inflammatory action of Con A have been proposed, including
histamine and serotonin release, mediators involved in Con A inflammation have
not been studied extensively.
Histamine is an early mediator of inflammation released from basophiles,
mast cells and platelets, mainly responsible for formation of edema. Histamine
induces various cellular responses via H1 receptors on vascular endothelial cells
including changes in vascular permeability as a result of cell contraction,
secretion and/or surface expression of mediators of inflammation (prostacyclin,
platelet-activating factor and leukotiene B4) and NO release (Leurs et al., 2002).
Histamine stimulates endothelial cells to express the adhesion molecules by
activating both the H1 and H2 receptors (Kubes and Kanwar, 1994), and
consequently stimulates endothelial-neutrophil adhesion. Delayed effects of
histamine on endothelial cells comprise H1 receptor-mediated increase in the
mRNA expression and secretion of neutrophil-attracting chemokine IL-8 (Jeannin
et al., 1994). Furthermore, H1 receptors mediate the histamine-induced
stimulation of respiratory burst in neutrophils (Benbarek et al., 1999) and the
increase in production of proinflammatory cytokine IL-6 in macrophages (Triggiani
et al., 2001). In addition, histamine exerts its proinflammatory effects via histamine
H4 receptors expressed on mast cells, dendritic cells, monocytes, eosinophils
and lymphocytes (Huang and Thurmond, 2008). Due to their high affinity to
histamine, (i.e. 1000 fold greater than the H1 receptors'), the H4 receptors respond
to lower histamine doses released by both immunological and non-
immunological stimuli. In contrast, the activation of H1 receptors requires high
concentration of histamine, like those typically found in inflammation immediately
upon mast cell degranulation. It has been shown that histamine exerts anti-
inflammatory activities, as well. Namely, histamine stimulates the synthesis of anti-
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inflammatory cytokine IL-10 via H2 receptors (Sirois et al., 2000) and inhibits the
synthesis of pro-inflammatory IL-12 (van der Pouw Kraan et al., 1998), IL-18 and
TNF (Yokoyama et al., 2004). Furthermore, H2 receptors have been shown to
negatively regulate the release of histamine from basophils and mast cells
(Lichtenstein et al., 1975).
Serotonin is a major neurotransmitter component of the inflammatory
chemical milieu, and may be released from platelets, mast cells, lymphocytes,
monocytes, macrophages and basophils that infiltrate areas of tissue damage; in
fact, platelets and mast cells can be viewed as mobile and stationary storage cells
for serotonin, respectively (Dray, 1995). Serotonin exerts similar proinflammatory
effects as histamine. A number of serotonin (5-hydroxytryptamine) receptor
classes (5HT1- 5HT7) have been identified in peripheral neuronal and non-
neuronal tissues. Serotonin 5HT3 receptor takes a special place as
phylogenetically much older, and as the only ligand-gated cation channel
receptor among the other serotonin receptors (Färber et al., 2004). It was
proposed that serotonin 5HT3 receptors are exclusively neuronal, both centrally
and peripherally (Fozard, 1984). However, 5HT3 receptors were also detected on
immune cells, especially upon Con A stimulation (Fiebich et al., 2004a; Stefulj et
al., 2000). Additionally, some specific 5HT3 receptor antagonists displayed anti-
inflammatory activity (Fiebich et al., 2004b).
In view of these facts, the present study was set up to test the hypothesis
that the difference in the intensity of paw edema in Dark Agouti (DA) and Albino
Oxford (AO) rat strains originates from the distinct participation of histamine,
serotonin and their corresponding receptors in Con A-induced inflammation. The
involvement of histamine and serotonin in Con A-induced paw edema was
investigated by the use of antagonists specific for histamine H1 and H2 and
serotonin 5-HT3 receptors. Since Ca2+ ions participate in the release of
inflammatory mediators (De Vries et al., 1995; Rodler et al., 1995) and the release
of peripheral nerves neurotransmitters involved in the control of local




Seven months old DA and AO male rats were obtained from our breeding
colony at Immunology Research Center "Branislav Jankovi}", Belgrade. Animals
were housed individually in perspex-walled cages with free access to food and
water. Colony conditions were maintained using 12 h light and 12 h dark cycles
(lights on at 08:00). All procedures involving animals were approved by the
Institutional Animal Care and Use Committee and followed the guidelines
described in the European Community's Council Directive dated 24th November
1986 (86/609/EEC).
Drugs
Specific antagonists for histamine H1 receptors (Chloropyramine
hydrochloride; N-p-Chlorobenzyl-N', N'-dimethyl-N-(2-pyridyl) ethylenediamine;
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Chl) and antagonist for serotonin 5HT3 receptors (Granisetron hydrochloride®;
Gran) were purchased from Pliva, Croatia. Histamine H2 receptor antagonist
(Ranitidine hydrochloride®; Ran) was obtained from Remevita, Serbia. Calcium
channel antagonist verapamil hydrochloride (5-(N-(3,4-Dimethoxyphenylethyl)
methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride;
Ver) was obtained from Galenika, Serbia (Izopamil®). Concanavalin A (isolated
from Canavalia ensiformis, type III) was acquired from Sigma (St. Louis, Mo.,
USA). All the drugs were dissolved in sterile, apyrogenic saline prepared from
purified water (with endotoxin units below the level of detection according to
limulus amoebocyte lysate (LAL) assay, Torlak Institute in Belgrade).
Induction of inflammation and treatments
Inflammatory edema was induced by a single intraplantar (i.pl.) injection
(i.e. into the dorsal part of the metatarsal region of hind paws) of Con A pH 7
(8 mg/mL saline, 400 g Con A in 50 L per paw).
Antagonists specific for histamine H1 (chloropyramine) and H2 (ranitidine),
receptors, and calcium channel blocker (verapamil) were intraplantarly injected at
the dose of 100 g per paw (2 mg/mL saline, 50 L per paw) 30 minutes prior to
Con A, while the control animals were injected with 50 L of saline per paw 30
minutes prior to Con A. The antagonist specific for serotonin 5HT3 receptors
(granisetron) was injected at 50 g per paw (1 mg/mL saline, 50 L per paw) in the
same manner. Separate groups of rats were i.pl. treated with 50 L of the specific
receptor antagonists or saline in the absence of inflammation.
To minimize animal discomfort during handling and i.pl. treatments, the rats
were briefly (1-3 min) exposed to isoflurane vapor and closely monitored for the
occurrence of early signs of sedation observed as behavioral tranquility and
calmness. This procedure permitted full recovery within a minute after the
treatment.
As maximal increase of paw diameter occurred 12 h and 9 h after induction
of inflammation in DA and AO rats, respectively, the intensity of inflammation was
determined by measuring the diameter of the tarso-metatarsal joints using a
nonius before, and 3, 6, 12, and 24 h after induction in DA rats and before, and 3,
6, 9 and 24 h after induction in AO rats. The number of rats per group was 6-8.
The results are expressed as relative increase of paw diameter (%)
according to the formula:
d rel = ((d after injection – d before injection) / d before injection) × 100
Statistical analysis
Statistical analysis of the data was performed using the SPSS 10.0
computer programme. The results were analyzed by one-way ANOVA and
Student's independent samples t-test. LSD and Scheffe tests were used for post
hoc analysis for the evaluation of the differences between independent groups. In
the figures, all data are displayed as mean ± (S.E.M.).
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RESULTS
Development of Con A-induced paw inflammation
Both rat strains developed inflammatory edema upon Con A injection that
was observed 24 h post-induction (Fig. 1). Local Con A injection did not cause a
spontaneous pain behavior in either of the strains, as judged by the absence of
limping or guarding of the affected hindpaws. As in our previous study (Stanojevi}
et al., 2006a), a maximal increase of paw diameter was observed 12 h after the
Con A injection in DA rats, reaching the levels of 70% increase over the controls
injected only with saline (Fig. 1, upper panel). AO rats exhibited substantially a
lower degree of paw inflammation reaching 40% of increase in paw diameter 9 h
after the induction with Con A (Fig. 1, lower panel). Some degree of tissue swelling
was observed in rats of AO strain during the first hours following the injection with
saline.
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Figure 1. Development of Concanavalin A (Con A)-induced paw edema in rats of DA (upper
panel) and AO (lower panel) strains. Values represent mean ± SE. Statistically
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The effect of histamine receptor antagonists on Con A-induced paw
inflammation
In DA rats, the H1 receptor antagonist chloropyramine decreased paw
diameter up to 12 h following the Con A injection, while the H2 receptor antagonist
ranitidine decreased it at all time points (Fig. 2, upper panel). In rats of the AO
strain, the i.pl. injection of chloropyramine gradually increased inflammation
following the pattern of Con A induced paw swelling, but with much higher
intensity (more than 80% of increase over the control 9 h post-injection, compared
to 40% in Con A-treated paws) and remained effective even 24 h after injection
(Fig. 2, lower panel). Histamine H2 receptor antagonist ranitidine exerted
proinflammatory activity as early as 3 h after the Con A injection in AO rats that
remained relatively unchanged for the next 6 hours and returned to the control
values within 24 h.
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Figure 2. The effect of i.pl. injection of 100 g of chloropyramine (Chl) and ranitidine (Ran)
on development of paw edema induced by Con A in rats of DA (upper panel) and AO
(lower panel) strains. Values represent mean ± SE. Statistically significant
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The effect of Ca2+ channel blocker and serotonin 5HT3 receptor antagonist
on Con A-induced paw inflammation
Ca2+ channel blocker verapamil enlarged the Con A-induced paw edema in
DA rats 6 h after inflammation induction, while serotonin 5HT3 receptor antagonist
granisteron decreased paw diameter 12 and 24 hours after Con A injection (Fig. 3,
upper panel). In AO rats, verapamil suppressed inflammation only 24 h after Con
A injection, while granisteron decreased Con A-induced inflammation 6, 9 and
24 h post-induction (Fig. 3, lower panel).
The effect of histamine receptor antagonists, Ca2+ channel blocker and
serotonin 5HT3 receptor antagonist on the diamater of non-inflamed paws
In DA rats all the antagonists exerted an edema-promoting effect. In AO rats,
chloropyramine and ranitidine increased paw diameter relative to saline-injected
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Figure 3. The effect of i.pl. injection of 100 g of verapamil (Ver) and 50 g of granisetron
(Gran) on development of paw edema induced by Con A in rats of DA (upper panel)
and AO (lower panel) strains. Values represent mean ± SE. Statistically significant

































paws, while verapamil and granisetron did not have any effect on the non-
inflamed paws. Actually, the level of the increase of the paw diameter induced by
verapamil and granisetron was comparable in two rat strains, but the increase
induced by saline was higher in AO rats resulting in the absence of the statistical
differences in verapamil and granisetron versus saline in this strain. Figure 4
shows representative results, i.e. 12 h post injection in DA and 9 h post injection in
AO rats.
DISCUSSION
The present study reflects the results from our previous experiments, in
which the i.pl. injected Con A exerted the edema-promoting effects in both rat
strains, with a substantially stronger intensity of inflammation in DA than in rats of
the AO strain (Stanojevi} et al., 2006a). Con A increases microvascular
permeability directly by binding to endothelial cells (Northover and Northover,
1994), but also indirectly by inducing histamine release from mast cells (Lopes et
al., 2005), which induces plasma extravasation at the post-capillary venules. This
is supported by the suppression of paw edema with antagonists of histamine H1
and H2 receptors in DA rats. It is in line with previous reports that H1 and H2
histamine receptor antagonists partially blocked zymosan-induced plasma
exudation, and H1 receptor antagonists reduced neutrophil influx (Kolaczkowska
et al., 2001).
Histamine effects are mostly related to a rapid increase in vascular
permeability, but in our model histamine antagonists were effective in blocking the
paw edema development up to 24 h after the Con A injection. Accordingly, some
histamine-liberating substances induce maximal paw edema at the moment when
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Figure 4. The effect of i.pl. injection of 100 g of chloropyramine (Chl), ranitidine (Ran) and
verapamil (Ver), and 50 g of granisetron (Gran) on the diameter of the non-inflamed
paws of DA and AO rat strains. Values represent mean ± SE. Statistically significant
differences: * p<0.05 and ** p<0.001 vs. saline























histamine content already returned to the basal levels (Guo et al., 1997). This
could be explained by the fact that gap formation in endothelial cells elicited by
histamine may persist longer than the metabolism of histamine. In addition, some
histamine effects might be related to a continuous histamine release. Although the
richest source of endogenous histamine are mast cells located around
vascularized tissues and nerves, in which granule-stored histamine is rapidly and
transiently liberated upon activation, it was shown that macrophages, T cells and
neutrophils, cells that are readily found in the inflammatory foci, can also produce
and release histamine, but in a rather continuous manner (Yokoyama et al., 2004;
Tanaka and Ichikawa, 2006). Along with many other inflammatory and immune
mediators, histamine and serotonin can also stimulate peptidergic afferent nerve
fibers or enhance their excitability and release vasoactive peptides, and in that
sense indirectly prolong inflammation (i.e. calcitonin gene related peptide
induces neurogenic dilatation of arterioles, substance P and neurokinins increase
venular permeability) (Holzer, 1998).
Since the differentiation of monocytes into macrophages enhances H1 and
suppresses H2 receptors expression (Wang et al., 2000), the more prominent
involvement of H2 histamine receptors during the Con A-induced inflammation
might point to a greater contribution of less mature (i.e. inflammatory) monocytes
in rats of the DA strain.
In contrast, histamine was not the primary inflammatory agent implicated in
the response induced by Con A in AO strain rats. Rather, it served to constrain
inflammation development as judged by aggravation of inflammation following
the pretreatment with both of the specific antagonists. As histamine inhibits the
synthesis and/or LPS-induced release of TNF in monocytes, while H2 receptor
antagonist ranitidine increases the release of TNF from mast cells (Bissonnette,
1996), it has been suggested that histamine acts as an autocrine regulator of
TNFá release, through histamine H2 receptors. Furthermore, histamine also
suppresses recruitment of neutrophils and macrophages upon ischemia/
reperfusion injury, air-pouch and pleural inflammation (Hiraga et al., 2007;
Hirasawa et al., 1991), acting via H2 receptors. The administration of H2 receptor
antagonists induces an increase of neutrophil infiltration (Hirasawa et al., 2002).
Inspite of general inflammation-promoting effects of H1 receptors, it has been also
shown that histamine via H1 receptors downregulates IL-12p70 production in
stimulated dendritic cells (Gutzmer et al., 2002). In that sense, a local application
of histamine H1 and H2 receptor antagonists might counteract antiinflammatory
effects of histamine in AO rats and aggravate inflammation. H1 and H2 antagonists
might nonspecifically liberate a variety of inflammatory mediators from mast cells
and thus indirectly augment lectin-induced inflammation.
We have shown that serotonin was involved in the Con A-induced paw
edema in both rat strains via 5HT3 receptors, since their blockade significantly
decreased paw diameter in the peak and late phases of inflammation in DA rats,
and in early, peak and late phase of inflammation in AO rats. Specific 5HT3
receptors were detected on immune cells, especially upon Con A stimulation
(Fiebich et al., 2004a; Stefulj et al., 2000). In addition, 5HT3 receptors are present
on capsaicin-sensitive sensory nerves and following their activation with serotonin
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they increase the release of inflammatory neuropeptides and in that way promote
inflammation (Hua and Yaksh, 1993). Nevertheless, the 5HT3 receptor antagonists
exerted an antiinflammatory effect by inhibition of TNF and IL-1 release from
human monocytes (Fiebich et al., 2004b). It seems that in Con A-induced
inflammation model resident immune cells in concert with those recruited to the
inflammation site can release serotonin, which binds to 5HT3 receptors and in
autocrine/paracrine way regulates and increases cytokine production in situ. The
effect of serotonin on 5HT3 receptors present on primary afferents in the
inflammatory focus can not be excluded.
The release of histamine and serotonin from mast cells is a Ca2+ dependant
process (Suzuki-Nishimura et al., 1989). Besides, it has been reported that
development of carrageenan-induced edema (Khaksari et al., 1999) and skin
inflammation (De Vries et al., 1995) in rats, as well as serotonin-induced paw
edema in mice (Cole et al., 1995) were blunted by Ca2+ antagonist. Con A induces
a rapid initial increase in intracellular concentration of Ca2+ and successive Ca2+
influx through Ca2+ channels (Ikegami et al., 1991). Accordingly, we have
expected that Ca2+ channel blocker verapamil could inhibit the increase in paw
diameter in Con A induced-inflammation. The finding that verapamil did not affect
paw inflammation in AO rats supports the notion that only intracellular Ca2+ is
required for mast cell histamine/serotonin release (Truneh and Pearce, 1981). In
contrast, the aggravation of paw swelling in DA rats following a treatment with
verapamil suggests its proinflammatory action. Several proinflammatory effects of
verapamil were described, such as stimulation of NO production (Sirmagul et al.,
2004) and rise in IL-6 production and successive increase in vascular permeability
(Rodler et al., 1995).
Although saline should be devoid of any inflammatory activity, the finding
that saline induced a slight paw edema in AO, but not in DA rats most likely
revealed strain differences in mast cell membrane stability. It has been reported
that trauma induced by needle penetration can activate small fiber sensory
neurons to release proinflammatory and proanalgesic substance P, neurokinins
and calcitonin gene-rated peptide and consequently cause a discharge of mast
cell inflammatory mediators (Guo et al., 1997). Saline injection induced a
significant increase in histamine release, but the level of histamine returned to
control values during the next 2 hours (Guo et al., 1997). In addition, the saline
injected into the upper surface of the rat paw in our experimental model could
disturb the organization of the subcutaneous tissue, e.g. by inducing an increase
in the thickness of connective tissue, separation of collagen fibers, and dilatation
of blood and lymphatic vessels (Daitoku et al., 2007), therefore contributing to a
transient edema formation in AO rats.
All antagonists used in our study increased the paw diameter in both rat
strains if injected in the non-inflamed paws. Such a uniform edema-promoting
behavior of antagonists is probably not due to the blockage of specific receptors
and prevention of binding of endogenous ligands, but rather to some unspecific
activity. As antagonists were injected at the dose of 100 g per paw, except
granistreon (50 g per paw), and their actual concentrations ranged from 3 to 7 x
10-3 M in tissue, it is most likely that their high concentration although safe for
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systemic application, exerted a damaging effect if injected locally in the paws. In
presence of inflammation, the primary proinflammatory effect of antagonists was
probably shifted towards the receptor-specific antagonistic activity against
mediators released following Con-A injection.
In general, our results showed that histamine mediated Con A-induced paw
edema in DA rats via H1 and H2 receptors, while serotonin participated in
inflammation in both DA and AO strains via 5HT3 receptors. Since histamine and
serotonin are co-stored and co-released from mast cells, it seems that strain
differences in Con A-induced inflammation may originate from different receptor
subtypes expressed on vascular endothelial cells in AO and DA rats. Extracellular
calcium ions were not involved in Con A-induced inflammation.
Strain differences found in the intensity and kinetics of inflammation
between DA and AO rats are most likely defined by the diversity of mediators
released and their receptors activated upon Con A injection. While still bearing in
mind the individual variations in building the inflammatory response, the model of
Con A-induced rat paw edema can be quite useful for determining the anti-
inflammatory potency of different pharmacological substances.
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RAZLIKE U EDEMU [APE PACOVA INDUKOVANOM KONKANAVALINOM A
U ZAVISNOSTI OD SOJA: UTICAJ HISTAMINSKIH H1 I H2 RECEPTORA
KU[TRIMOVI] NATA[A, MITI] KATARINA, DIMITRIJEVI] MIRJANA, VUJI] VESNA,
KOVA^EVI]-JOVANOVI] VESNA, MILETI] TATJANA i STANOJEVI] STANISLAVA
SADR@AJ
Testirana je hipoteza da razlike u intenzitetu inflamatornog edema {ape in-
dukovanog konkanavalinom A u pacova Dark Agouti (DA) i Albino Oxford (AO)
soja poti~u od razli~itog doprinosa histamina i serotonina i njihovih odgovaraju}ih
receptora. Mu`jaci pacova DA i AO soja su intraplantarno tretirani antagonistima
specifi~nih receptora pre izazivanja inflamacije konkanavalinom A i intenzitet infla-
macije je pra}en merenjem dijametra {ape.
Na{i rezultati su ukazali da antagonisti histaminskih H1 i H2 receptora sman-
juju edem {ape indukovan konkanavalinom A u DA pacova, dok antagonist sero-
toninskih 5HT3 receptora smanjuje edem {ape u oba soja pacova. Blokator kalci-
jumskih kanala ne uti~e na inflamaciju izazvanu konkanavalinom A.
Razlike u intenzitetu i kinetici inflamatornog odgovora indukovanog konka-
navalinom A izme|u DA i AO sojeva su najverovatnije posledica razlika u oslo-
bo|enim medijatorima i aktivaciji odgovaraju}ih receptora nakon injekcije kon-
kanavalina A.
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